This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Brain arteriovenous malformations (AVMs), cerebral cavernous malformations (CCMs), and intracranial aneurysms are major causes of hemorrhagic stroke, yet noninvasive therapies to prevent growth or rupture are lacking. Stroke, Ahead of Print.
Katie Lin for a deep dive into why we still miss this life-threatening diagnosis, the key clinical clues, proper use of decision tools, indications for CT, indications for CTA, indications for LP and CSF interpretation for the sometimes elusive diagnosis of subarachnoid hemorrhage.
This makes it particularly interesting for preclinical treatment of hemorrhagic shock. Relatively small volume injections of solutions of a novel star-shaped polymer could compensate for the loss of fluid without disrupting coagulation, according to a new study published in the journal Angewandte Chemie International Edition.
Taking an anticoagulant, or blood-thinning medication, can increase one's risk of—or exacerbate—a brain bleed, also known as a brain hemorrhage, which is the deadliest type of stroke. Now, new research finds that faster treatment for these patients is associated with a greater likelihood of survival.
ObjectivesComplications of intracranial hemorrhage (ICH) after percutaneous coronary intervention (PCI), although rare, have a poor prognosis with high mortality rates.
Recovery trajectories in intracerebral hemorrhage (ICH) are recognized as distinct from those observed in ischemic stroke. Stroke, Ahead of Print. This narrative review aims to clarify the pathophysiology underlying ICH recovery patterns, highlighting the unique timeline and nature of functional improvements seen in ICH survivors.
Extreme heat and extreme cold are both associated with increased risks of death from ischemic and hemorrhagic stroke, according to a new study. The researchers found that the link between extreme temperatures and stroke mortality was stronger in low-income countries than in high-income countries.
Researchers found an artificial intelligence (AI) system to help guide treatment decisions for stroke patients led to improved stroke care quality and fewer recurrent strokes, heart attacks and vascular death among stroke survivors three months after a stroke.
These brain bleeds, known as symptomatic intracerebral hemorrhages, are considered one of the most dangerous complications of ischemic stroke treatment. These data suggest that more focus and research is needed on the management of high blood sugar in the treatment of stroke patients, particularly those with higher risk, more severe strokes.”
To tackle this problem, researchers compared Veterans Affairs data on 2 million T2D patients (2017-2023) taking either GLP-1s , DPP4is, SGLT2is, or usual care antihyperglycemics over a 3.68 As expected, GLP-1s reduced MI risk by 9%, cardiac arrest by 22%, incident HF by 11%, ischemic stroke by 7%, and hemorrhagic stroke by 14%.
However, new research published Jan. 22 in JAMA shows that message has not reached all population segments equally, leaving some groups at greater risk of adverse effects like gastrointestinal bleeding and intracerebral hemorrhage.
Fully published results from Athos Therapeutics AZALEA-TIMI 71 trial for its novel Factor XI inhibitor abelacimab, confirming the drugs lower bleeding risks, but leaving researchers uncertain about its ability to prevent stroke in AFib patients. year follow-up. per 100 person-years vs. 0.83).
Research Highlights: Among most ischemic (clot-caused) stroke survivors including those taking anticoagulant medications, use of antidepressants in the SSRI or SNRI class did not increase the risk of hemorrhagic (bleeds) stroke or other serious.
Regular physical activity and exercise may reduce bleeding in individuals with intracerebral hemorrhage, a new study shows. The researchers emphasize the importance of physical activity to protect the brain.
Subarachnoid hemorrhage is a critical neurological condition accounting for about 5% of all strokes, and survivors experience long-term cognitive deterioration and increased risk of dementia. Genetic predispositions have been associated with post-subarachnoid hemorrhage cognitive outcomes and emphasize a role for personalized care strategies.
The research group of Susanne Wegener, professor at the University of Zurich (UZH) and senior leading physician at the Department of Neurology of the University Hospital Zurich (USZ), has now demonstrated that the outcome of stroke treatments depends on the collateral network.
A new study has revealed a new culprit in the formation of brain hemorrhages that does not involve injury to the blood vessels, as previously believed.
Hemorrhagic stroke (HS), including non-traumatic intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH), constitutes a substantial proportion of cerebrovascular incidents, accounting for around 30% o.
However, heterogeneity was observed in studies assessing outcomes such as intraventricular hemorrhage and Glasgow Coma Scale (GCS), indicating variability in populations or methodologies.Conclusion:One of the significant life-threatening condicions is ICH, and patients are associated with poor prognosis. 0.57 (p < 0.00001).
Lifelong use of oral anticoagulants reduces the risk of these ischemic events but increases the risk of major and clinically relevant hemorrhages. The benefits, risks, and shortcomings of these treatments and future research required in different high-risk patient populations are reviewed in this consensus statement.
It has articles, ranging from from simple clinical studies on postpartum hemorrhage (E-MOTIVE study) from deep inside Africa by Melinda Gate foundation, to Dupilumab for COPD, a stunning monoclonal antibody inhibitor of IL-4 for COPD exacerbations.
BackgroundDelayed cerebral ischemia represents a significant contributor to death and disability following aneurysmal subarachnoid hemorrhage. In murine studies (n=30), the endovascular perforation model was predominantly used, while rat studies primarily employed intracisternal blood injection to mimic subarachnoid hemorrhage.
Background:FDA clearance of fully automated artificial intelligence (AI)-based software for quantifying intracerebral hemorrhage (ICH) volumes has the potential to meaningfully impact the acute management of hemorrhagic stroke. Quantifying ICH volume in OAC-related ICH presents challenges due to variability of morphology and density.
Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients. These findings support further research into whether polygenic profiling can improve clinical decision-making in AF patients. Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025.
Introduction:Intracerebral hemorrhage (ICH) incidence follows both seasonal and diurnal patterns noted in the literature. Further research is required to elucidate the potential underlying mechanisms for these differences. Stroke, Volume 55, Issue Suppl_1 , Page ATP171-ATP171, February 1, 2024. ml, p = 0.002) or evening (13.0
Introduction:A recent randomized-controlled trial confirmed the value of minimally-invasive intracerebral hemorrhage (ICH) evacuation to improve outcomes in properly-selected patients. Stroke, Volume 56, Issue Suppl_1 , Page ATMP52-ATMP52, February 1, 2025.
Introduction:Incident intracerebral hemorrhage (ICH) is an uncommon medical event that can lead to devastating outcomes, including death. Further research is needed to observe if MRI could be used to screen subjects at high-risk for elevated risk of incident ICH. Stroke, Volume 55, Issue Suppl_1 , Page ATMP79-ATMP79, February 1, 2024.
Approximately 30% of aneurysmal subarachnoid hemorrhage (aSAH) patients who survive the rupture develop delayed cerebral ischemia (DCI) 4 to 10 days following aSAH. However, further research with a larger patient cohort is necessary to validate these findings. Stroke, Volume 56, Issue Suppl_1 , Page AWP370-AWP370, February 1, 2025.
Background:Direct oral anticoagulants (DOAC) are associated with an increased risk ofhematoma expansion (HE) in spontaneous intracerebral hemorrhage (ICH). Further research in multicenter cohorts is necessary to better delineate the relationship between specific DOAC levels and the risk of HE.
Background:Amyloid-related Imaging Abnormalities (ARIA) are adverse effects that occur during amyloid beta monoclonal antibody treatment for Alzheimer's disease, including edema-type ARIA and hemorrhage-type ARIA. Besides, ARIA-H is associated with the characteristics of mAb. (1)More
Intracerebral Hemorrhagic (ICH) stroke is the second most common type of stroke and its aftermath is often more severe than ischemia. Hence, our research is looking into the effects of electrical stimulation of the perihematomal cortex in the hyperacute/acute phase post ICH.
Objective:In clinical practice, initial neurological status such as impaired consciousness is believed to correlate with patient outcomes in subarachnoid hemorrhage (SAH). This study aimed to develop an evaluation method that overcomes these limitations.Methods:A SAH model was created using Sprague-Dawley rats (Male, 280320 g).
Introduction:Elevated levels of Interleukin-6 (IL-6) levels in cerebrospinal fluid (CSF) have been correlated with delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). However, the role of neuroinflammation in SAH pathophysiology remains incompletely understood.
Evidence of this association in real-world intracerebral hemorrhage (ICH) hospitalization is lacking, however.Methods:Data for adult (≥18) patients with primary ICH were retrieved from the REINAH cerebrovascular research database.
IntroductionSubarachnoid Hemorrhage (SAH) resulting from the spontaneous rupture of an aneurysm is a rare and highly debilitating condition. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023.
IntroductionNontraumatic Intracerebral Hemorrhage (ICH) is the second most prevalent type of stroke worldwide and is strongly linked with severe disability and mortality. However, further research is required to validate this hypothesis and to identify other potentially modifiable risk factors.
Background:The Medical Research Council (MRC) scale is used to assess the impact of stroke on muscle strength. Males=147; Right Hemisphere=131; Ischemic=199, Hemorrhagic=27). Stroke, Volume 56, Issue Suppl_1 , Page AWMP42-AWMP42, February 1, 2025. PREP-2), and been recommended for use in screening for clinical trials.
The primary safety endpoint was symptomatic intracranial hemorrhage (sICH) which was observed at a rate of 6.5%. Cognard , Dr. Elijovich and Dr. Jankowitz , as well as all site investigators and research teams that participated in the EvaQ Trial in the U.S. mTICI 2b/3. and France. following FDA clearance.
Introduction:Stroke is a leading cause of maternal morbidity and mortality, and hemorrhagic strokes account for up to half of these cases. Patients with insufficient data for a determination were categorized as no diagnostic delay.Results:A total of 121 patients were identified, of whom 48% had hemorrhagic stroke.
12, I60-69), clinical data was extracted by a research nurse and adjudicated by physicians. We determined the ability of prehospital LVO triage scores to identify ICH patients and to discriminate lobar from non-lobar ICH.Methods:We identified ICH cases presenting to the ED in Greater Cincinnati/Northern Kentucky in 2005, 2010, and 2015.
Louis, Missouri christine.book Wed, 02/07/2024 - 17:23 February 7, 2024 — Researchers presenting preliminary late-breaking science presented on the first day of the American Stroke Association ’s International Stroke Conference , ISC 2024 , reported findings from the highly-anticipated MOST (Multi-Arm Optimization of Stroke Thrombolysis) trial.
Other select data from research studies unveiled last week at the American Heart Association ’s International Stroke Conference (ISC) underscore and reinforce the pivotal role of the RapidAI platform in advancing stroke care. Key imaging criteria: target mismatch ratio of ≥1.8,
BackgroundPrevious research on how changes in CRP (Creactive protein) levels predict stroke risk is limited. The group that remained at a high level also had a heightened hemorrhagic stroke risk (HR, 1.91 [95% CI, 1.073.44]). Journal of the American Heart Association, Ahead of Print. Similar trends were observed for ischemic stroke.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content